<HashMap><database>biostudies-literature</database><scores/><additional><submitter>He Y</submitter><funding>NCI NIH HHS</funding><pagination>e2200905</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11117022</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(15)</volume><pubmed_abstract>With the advent of bioinformatic tools in efficiently predicting neo-antigens, peptide vaccines have gained tremendous attention in cancer immunotherapy. However, the delivery of peptide vaccines remains a major challenge, primarily due to ineffective transport to lymph nodes and low immunogenicity. Here, a strategy for peptide vaccine delivery is reported by first fusing the peptide to the cytosolic domain of the stimulator of interferon genes protein (STINGΔTM), then complexing the peptide-STINGΔTM protein with STING agonist 2'3' cyclic guanosine monophosphate-adenosine monophosphate (cGAMP). The process results in the formation of self-assembled cGAMP-peptide-STINGΔTM tetramers, which enables efficient lymphatic trafficking of the peptide. Moreover, the cGAMP-STINGΔTM complex acts not o</pubmed_abstract><journal>Advanced healthcare materials</journal><pubmed_title>Peptide-Based Cancer Vaccine Delivery via the STINGΔTM-cGAMP Complex.</pubmed_title><pmcid>PMC11117022</pmcid><funding_grant_id>P30 CA014051</funding_grant_id><pubmed_authors>Fletcher SJ</pubmed_authors><pubmed_authors>Irvine DJ</pubmed_authors><pubmed_authors>Huang S</pubmed_authors><pubmed_authors>Belcher AM</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>He Y</pubmed_authors><pubmed_authors>Yang M</pubmed_authors><pubmed_authors>Berger AG</pubmed_authors><pubmed_authors>Hammond PT</pubmed_authors><pubmed_authors>Sun X</pubmed_authors><pubmed_authors>Hong C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Peptide-Based Cancer Vaccine Delivery via the STINGΔTM-cGAMP Complex.</name><description>With the advent of bioinformatic tools in efficiently predicting neo-antigens, peptide vaccines have gained tremendous attention in cancer immunotherapy. However, the delivery of peptide vaccines remains a major challenge, primarily due to ineffective transport to lymph nodes and low immunogenicity. Here, a strategy for peptide vaccine delivery is reported by first fusing the peptide to the cytosolic domain of the stimulator of interferon genes protein (STINGΔTM), then complexing the peptide-STINGΔTM protein with STING agonist 2'3' cyclic guanosine monophosphate-adenosine monophosphate (cGAMP). The process results in the formation of self-assembled cGAMP-peptide-STINGΔTM tetramers, which enables efficient lymphatic trafficking of the peptide. Moreover, the cGAMP-STINGΔTM complex acts not o</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2026-07-15T07:55:39.294Z</modification><creation>2026-07-01T03:11:02.236Z</creation></dates><accession>S-EPMC11117022</accession><cross_references><pubmed>35670244</pubmed><doi>10.1002/adhm.202200905</doi></cross_references></HashMap>